The RTS,S/AS01 Malaria Vaccine in Children 5 to 17 Months of Age at First Vaccination

Expert Review of Vaccines - United Kingdom
doi 10.1080/14760584.2016.1236689
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Statistical Methodology for the Evaluation of Vaccine Efficacy in a Phase III Multi-Centre Trial of the RTS,S/AS01 Malaria Vaccine in African Children

Malaria Journal
ParasitologyInfectious Diseases
2011English

CNS Infection Safety Signal of RTS,S/AS01 and Possible Association With Rabies Vaccine

The Lancet
Medicine
2016English

Systems Analysis of Protective Immune Responses to RTS,S Malaria Vaccination in Humans

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

Assessment of Severe Malaria in a Multicenter, Phase III, RTS, S/As01 Malaria Candidate Vaccine Trial: Case Definition, Standardization of Data Collection and Patient Care

Malaria Journal
ParasitologyInfectious Diseases
2011English

Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

New England Journal of Medicine
Medicine
2008English

Policy Analysis for Deciding on a Malaria Vaccine RTS,S in Tanzania

Malaria Journal
ParasitologyInfectious Diseases
2016English

Efficacy and Safety of RTS,S/AS01 Malaria Vaccine With or Without a Booster Dose in Infants and Children in Africa: Final Results of a Phase 3, Individually Randomised, Controlled Trial

The Lancet
Medicine
2015English

Characterization of T-Cell Immune Responses in Clinical Trials of the Candidate RTS,S Malaria Vaccine

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2017English

Differential Patterns of IgG Subclass Responses to Plasmodium Falciparum Antigens in Relation to Malaria Protection and RTS,S Vaccination

Frontiers in Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy